News | May 25, 2021
Lincoln consolidated Q4FY21 net profit at Rs. 12.57 Cr
The company plans to enter the EU markets in FY22
The company plans to enter the EU markets in FY22
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021
Drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday
Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.
This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19
This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.
Subscribe To Our Newsletter & Stay Updated
